MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ResMed Company Profile (NYSE:RMD)

Consensus Ratings for ResMed (NYSE:RMD) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Hold Rating(s), 3 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Hold (Score: 2.36)
Consensus Price Target: C$57.92 (0.90% downside)

Analysts' Ratings History for ResMed (NYSE:RMD)
Show:
DateFirmActionRatingPrice TargetActions
4/27/2016BMO Capital MarketsReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016MacquarieUpgradeUnderperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Citigroup Inc.UpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Piper JaffrayDowngradeOverweight -> Neutral$65.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2016BarclaysInitiated CoverageUnderweight$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2016Credit SuisseUpgradeNeutral -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015Deutsche BankUpgradeSell -> Hold$53.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2015Goldman SachsUpgradeNeutral -> Conviction-BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Morgan StanleyUpgradeEqual Weight -> OverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Jefferies GroupSet Price TargetHold$65.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Bank of AmericaDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2015Northland SecuritiesBoost Price TargetHold -> Under Perform$40.00 -> $44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/24/2014William BlairUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2014JPMorgan Chase & Co.UpgradeNeutral -> OverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha